Journal for ImmunoTherapy of Cancer · 2024 · 18 citations · 39 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyDendritic Cell BiologyImmune Checkpoint ModulationImmune Checkpoint RegulationImmune CheckpointsTumor Immune MicroenvironmentDendritic Cell-t Cell InteractionImmune Tolerance RestorationImmunosuppressive MicroenvironmentInhibitory Checkpoint RegulationInhibitory Checkpoint SignalingInnate Immune Checkpoint RegulationSingle-cell Rna SequencingTolerogenic Dendritic Cells
Background The occurrence of chronic inflammation resulting from infection with human papillomaviruses is an important factor in the development of cervical cancer (CC); thus, deciphering the crosstalk between the tumor microenvironment and innate immune cells during the establishment of immune tolerance is vital for identifying potential treatment strategies. Methods Single-cell RNA sequencing data and primary tumor samples from patients with CC were used to evaluate the functional role of Siglec-10 on dendritic cells (DCs). Patient-derived tumor fragment platforms were used to examine the ability of Siglec-10 blockade to reinvigorate DC-mediate T-cell activation and tumor clearance. Results Here, we demonstrated that Siglec-10 is a prominent inhibitory checkpoint for DCs infiltrated in CC. CC epithelial cells use their aberrant surface sialylated structures to induce the transformation of conventional DCs into phenotypes characterized by low immunogenicity and high immunotolerance. Additionally, Siglec-10 + DCs suppress the function of adaptive T cells via galectin-9 signaling to strengthen the immunosuppressive CC microenvironment. Disturbance of Siglec-10 signaling restored the DC-mediated tumoricidal response and increased adaptive T cells sensitivity to programmed cell death protein 1 inhibition. Conclusion Our study confirms the checkpoint role of Siglec-10 on DCs and proposes that targeting Siglec-10 may be a promising avenue for immunotherapy against CC.
39
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Chen Zhu, Ana C. Anderson, Anna Schubart et al. · Nature Immunology · 2005 · 2K citations
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Sijin Cheng, Ziyi Li, Ranran Gao et al. · Cell · 2021 · 1.6K citations · Full text
Medicine, Cancer Biology, Oncology +17
Deependra Singh, Jérôme Vignat, Valentina Lorenzoni et al. · The Lancet Global Health · 2022 · 1.5K citations · Full text
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei, Alexander Ploner, K. Miriam Elfström et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira Barkal, Rachel Brewer, Maxim Markovic et al. · Nature · 2019 · 1.4K citations
Life Sciences, Immunology, Oncology +14